Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder, Neurogenic | 48 | 2024 | 174 | 7.750 |
Why?
|
Urodynamics | 70 | 2024 | 350 | 7.140 |
Why?
|
Urinary Bladder | 63 | 2023 | 1170 | 4.810 |
Why?
|
Urinary Incontinence | 36 | 2021 | 492 | 3.510 |
Why?
|
Intermittent Urethral Catheterization | 4 | 2023 | 13 | 3.120 |
Why?
|
Urination Disorders | 22 | 2018 | 242 | 2.760 |
Why?
|
Urinary Tract | 21 | 2023 | 309 | 2.560 |
Why?
|
Meningomyelocele | 22 | 2012 | 164 | 2.380 |
Why?
|
Urethra | 32 | 2020 | 404 | 2.190 |
Why?
|
Vesico-Ureteral Reflux | 39 | 2022 | 438 | 1.960 |
Why?
|
Urinary Bladder Diseases | 17 | 2016 | 170 | 1.560 |
Why?
|
Urologic Diseases | 7 | 2016 | 247 | 1.510 |
Why?
|
Neural Tube Defects | 12 | 2017 | 253 | 1.500 |
Why?
|
Botulinum Toxins, Type A | 4 | 2024 | 224 | 1.470 |
Why?
|
Spinal Dysraphism | 7 | 2024 | 172 | 1.440 |
Why?
|
Urogenital Abnormalities | 9 | 2022 | 255 | 1.250 |
Why?
|
Urology | 7 | 2024 | 421 | 1.200 |
Why?
|
Nocturnal Enuresis | 4 | 2019 | 12 | 1.070 |
Why?
|
Urinary Bladder, Overactive | 5 | 2021 | 114 | 1.050 |
Why?
|
Diagnostic Techniques, Urological | 4 | 2015 | 28 | 1.050 |
Why?
|
Fecal Incontinence | 5 | 2015 | 242 | 1.020 |
Why?
|
Neuromuscular Agents | 3 | 2024 | 143 | 0.940 |
Why?
|
Child | 175 | 2024 | 79427 | 0.920 |
Why?
|
Ureter | 15 | 2016 | 378 | 0.890 |
Why?
|
Urinary Tract Infections | 15 | 2023 | 814 | 0.860 |
Why?
|
Urinary Catheterization | 12 | 2023 | 202 | 0.710 |
Why?
|
Urination | 13 | 2022 | 204 | 0.680 |
Why?
|
Losartan | 1 | 2021 | 259 | 0.660 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2021 | 438 | 0.600 |
Why?
|
Defecation | 3 | 2017 | 190 | 0.570 |
Why?
|
Child, Preschool | 110 | 2024 | 41893 | 0.560 |
Why?
|
Constipation | 5 | 2015 | 555 | 0.550 |
Why?
|
Terminology as Topic | 5 | 2015 | 1532 | 0.500 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2019 | 595 | 0.490 |
Why?
|
Spinal Cord | 11 | 2017 | 1808 | 0.480 |
Why?
|
Urologic Surgical Procedures | 6 | 2024 | 308 | 0.450 |
Why?
|
Fibrosis | 1 | 2021 | 2018 | 0.450 |
Why?
|
Cerebral Palsy | 3 | 2017 | 472 | 0.450 |
Why?
|
Varicocele | 6 | 2015 | 78 | 0.430 |
Why?
|
Urethral Diseases | 4 | 2018 | 53 | 0.430 |
Why?
|
Infant | 85 | 2020 | 35867 | 0.420 |
Why?
|
Neurogenic Bowel | 1 | 2012 | 1 | 0.420 |
Why?
|
Ureteral Obstruction | 11 | 2011 | 294 | 0.420 |
Why?
|
Digestive System Abnormalities | 1 | 2012 | 49 | 0.400 |
Why?
|
Glycopeptides | 1 | 2013 | 220 | 0.400 |
Why?
|
Syringomyelia | 1 | 2012 | 67 | 0.390 |
Why?
|
Humans | 231 | 2024 | 755533 | 0.390 |
Why?
|
Writing | 1 | 2013 | 200 | 0.380 |
Why?
|
Kidney | 23 | 2022 | 7009 | 0.380 |
Why?
|
Biofeedback, Psychology | 2 | 2009 | 115 | 0.380 |
Why?
|
Urography | 11 | 2016 | 314 | 0.380 |
Why?
|
Adolescent | 93 | 2024 | 87236 | 0.370 |
Why?
|
Antidiuretic Agents | 2 | 2012 | 23 | 0.370 |
Why?
|
Consensus | 7 | 2024 | 3057 | 0.360 |
Why?
|
Intestines | 5 | 2017 | 1901 | 0.360 |
Why?
|
Deamino Arginine Vasopressin | 2 | 2012 | 88 | 0.360 |
Why?
|
Mandelic Acids | 4 | 1999 | 46 | 0.360 |
Why?
|
Urinary Sphincter, Artificial | 2 | 2008 | 23 | 0.350 |
Why?
|
Pediatrics | 5 | 2024 | 3582 | 0.330 |
Why?
|
Quality of Life | 5 | 2017 | 13201 | 0.330 |
Why?
|
Diverticulum | 4 | 2009 | 138 | 0.330 |
Why?
|
Self Concept | 1 | 2015 | 1027 | 0.330 |
Why?
|
Male | 161 | 2024 | 356577 | 0.320 |
Why?
|
Hydronephrosis | 15 | 2011 | 272 | 0.320 |
Why?
|
Kidney Pelvis | 4 | 2017 | 188 | 0.310 |
Why?
|
Hypospadias | 8 | 2001 | 98 | 0.310 |
Why?
|
Infant, Newborn | 52 | 2018 | 26039 | 0.300 |
Why?
|
Intestine, Small | 1 | 2014 | 1201 | 0.300 |
Why?
|
Patient Satisfaction | 2 | 2022 | 3440 | 0.290 |
Why?
|
Cholinergic Antagonists | 4 | 2003 | 164 | 0.290 |
Why?
|
Tissue Engineering | 3 | 2014 | 1861 | 0.290 |
Why?
|
Pressure | 6 | 2018 | 1149 | 0.280 |
Why?
|
Fetus | 3 | 2012 | 1887 | 0.280 |
Why?
|
Guidelines as Topic | 1 | 2013 | 1391 | 0.280 |
Why?
|
Patient Compliance | 4 | 2015 | 2684 | 0.280 |
Why?
|
Urethral Stricture | 3 | 2017 | 51 | 0.280 |
Why?
|
Toilet Training | 2 | 2019 | 18 | 0.270 |
Why?
|
Fetal Diseases | 2 | 2011 | 912 | 0.270 |
Why?
|
Enuresis | 4 | 2006 | 50 | 0.260 |
Why?
|
Testis | 7 | 2015 | 792 | 0.260 |
Why?
|
Female | 129 | 2024 | 387920 | 0.260 |
Why?
|
Bladder Exstrophy | 4 | 2014 | 106 | 0.250 |
Why?
|
Bulbourethral Glands | 1 | 2004 | 7 | 0.250 |
Why?
|
Spina Bifida Occulta | 4 | 2000 | 31 | 0.240 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2304 | 0.240 |
Why?
|
Sacrum | 5 | 2012 | 280 | 0.240 |
Why?
|
Postoperative Complications | 20 | 2011 | 15576 | 0.240 |
Why?
|
Urinary Diversion | 10 | 2003 | 135 | 0.240 |
Why?
|
Adaptation, Psychological | 1 | 2015 | 2606 | 0.230 |
Why?
|
Genital Diseases, Male | 1 | 2004 | 83 | 0.230 |
Why?
|
Muscle, Smooth | 5 | 2015 | 923 | 0.230 |
Why?
|
Adolescent Behavior | 1 | 2012 | 1182 | 0.220 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3001 | 0.220 |
Why?
|
Guideline Adherence | 1 | 2013 | 2278 | 0.210 |
Why?
|
Meningocele | 3 | 2016 | 45 | 0.200 |
Why?
|
Ureteral Neoplasms | 1 | 2003 | 111 | 0.200 |
Why?
|
Periodicals as Topic | 1 | 2013 | 1457 | 0.200 |
Why?
|
Central Nervous System Neoplasms | 1 | 2010 | 906 | 0.200 |
Why?
|
Pedigree | 8 | 2020 | 4577 | 0.200 |
Why?
|
Polyps | 2 | 2003 | 198 | 0.200 |
Why?
|
Reproducibility of Results | 9 | 2022 | 19987 | 0.200 |
Why?
|
Electromyography | 18 | 2020 | 1378 | 0.190 |
Why?
|
Caregivers | 2 | 2023 | 2190 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 804 | 0.180 |
Why?
|
Clinical Protocols | 2 | 2016 | 1436 | 0.180 |
Why?
|
Ureterostomy | 1 | 2000 | 18 | 0.180 |
Why?
|
Cystostomy | 1 | 2000 | 25 | 0.180 |
Why?
|
Retrospective Studies | 36 | 2024 | 79686 | 0.180 |
Why?
|
Urologic Surgical Procedures, Male | 3 | 2017 | 76 | 0.180 |
Why?
|
Urinary Bladder Neck Obstruction | 2 | 2000 | 81 | 0.180 |
Why?
|
Spasm | 1 | 2000 | 133 | 0.170 |
Why?
|
Young Adult | 14 | 2022 | 58025 | 0.170 |
Why?
|
Ketorolac | 1 | 2000 | 93 | 0.170 |
Why?
|
Cysts | 2 | 2004 | 685 | 0.170 |
Why?
|
Video Recording | 3 | 2015 | 945 | 0.170 |
Why?
|
Hospitals, Pediatric | 5 | 2024 | 1847 | 0.160 |
Why?
|
Solanaceous Alkaloids | 1 | 2018 | 3 | 0.160 |
Why?
|
Fraser Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
Orchiopexy | 1 | 2017 | 20 | 0.150 |
Why?
|
Fatty Acids, Volatile | 1 | 2018 | 99 | 0.150 |
Why?
|
Follow-Up Studies | 31 | 2019 | 39179 | 0.150 |
Why?
|
Eye Abnormalities | 1 | 2020 | 243 | 0.150 |
Why?
|
Sacrococcygeal Region | 2 | 2016 | 54 | 0.150 |
Why?
|
Parasympatholytics | 3 | 1994 | 88 | 0.150 |
Why?
|
Genetic Linkage | 3 | 2012 | 2385 | 0.140 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2018 | 176 | 0.140 |
Why?
|
Urethral Obstruction | 1 | 1997 | 55 | 0.140 |
Why?
|
Rheology | 1 | 2018 | 346 | 0.140 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2019 | 269 | 0.140 |
Why?
|
Urinary Reservoirs, Continent | 4 | 1998 | 29 | 0.140 |
Why?
|
Mutation | 5 | 2020 | 29807 | 0.140 |
Why?
|
Receptors, Nicotinic | 1 | 2019 | 497 | 0.130 |
Why?
|
Cystoscopy | 6 | 2011 | 135 | 0.130 |
Why?
|
Forkhead Transcription Factors | 2 | 2020 | 1597 | 0.130 |
Why?
|
Kidney Diseases | 7 | 2012 | 2061 | 0.130 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2018 | 167 | 0.130 |
Why?
|
Societies, Medical | 4 | 2015 | 3856 | 0.130 |
Why?
|
Diurnal Enuresis | 1 | 2015 | 3 | 0.130 |
Why?
|
Urinary Incontinence, Urge | 3 | 2015 | 50 | 0.130 |
Why?
|
Muscle Weakness | 1 | 2018 | 412 | 0.120 |
Why?
|
Disease Management | 2 | 2016 | 2484 | 0.120 |
Why?
|
Age Factors | 7 | 2015 | 18366 | 0.120 |
Why?
|
Sports | 1 | 2021 | 693 | 0.120 |
Why?
|
Predictive Value of Tests | 5 | 2015 | 15197 | 0.120 |
Why?
|
Urinary Tract Physiological Phenomena | 1 | 2014 | 11 | 0.120 |
Why?
|
Stomach | 4 | 2000 | 696 | 0.120 |
Why?
|
Tretinoin | 1 | 2017 | 523 | 0.120 |
Why?
|
Self Care | 4 | 2012 | 789 | 0.110 |
Why?
|
Spinal Cord Injuries | 4 | 2008 | 920 | 0.110 |
Why?
|
Sperm Motility | 1 | 2015 | 266 | 0.110 |
Why?
|
Abnormalities, Multiple | 4 | 2016 | 1419 | 0.110 |
Why?
|
Students | 1 | 2023 | 1704 | 0.110 |
Why?
|
Social Participation | 1 | 2015 | 182 | 0.110 |
Why?
|
Semen Analysis | 1 | 2015 | 230 | 0.110 |
Why?
|
Intestinal Diseases | 1 | 2017 | 504 | 0.110 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 463 | 0.110 |
Why?
|
Treatment Outcome | 21 | 2016 | 64535 | 0.110 |
Why?
|
Cryptorchidism | 3 | 1999 | 126 | 0.100 |
Why?
|
Pilot Projects | 2 | 2016 | 8487 | 0.100 |
Why?
|
Genes, Dominant | 1 | 2015 | 865 | 0.100 |
Why?
|
Social Adjustment | 1 | 2015 | 633 | 0.100 |
Why?
|
Anal Canal | 2 | 2012 | 371 | 0.100 |
Why?
|
Ureterocele | 3 | 2001 | 28 | 0.100 |
Why?
|
Urinary Calculi | 3 | 2001 | 91 | 0.100 |
Why?
|
Time Factors | 16 | 2016 | 39961 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2012 | 410 | 0.100 |
Why?
|
Parents | 2 | 2022 | 3530 | 0.090 |
Why?
|
Genes, X-Linked | 1 | 2011 | 128 | 0.090 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2000 | 83 | 0.090 |
Why?
|
Pain | 3 | 2020 | 4999 | 0.090 |
Why?
|
Enema | 1 | 2011 | 140 | 0.090 |
Why?
|
Practice Guidelines as Topic | 4 | 2017 | 7434 | 0.090 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1991 | 172 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2270 | 0.090 |
Why?
|
Rectum | 2 | 2012 | 896 | 0.090 |
Why?
|
Administration, Intravesical | 2 | 2004 | 91 | 0.090 |
Why?
|
Death, Sudden | 1 | 2012 | 306 | 0.090 |
Why?
|
Mutation, Missense | 2 | 2018 | 2561 | 0.090 |
Why?
|
Infant Care | 1 | 2011 | 180 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8167 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 25696 | 0.080 |
Why?
|
Prognosis | 6 | 2019 | 29423 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2974 | 0.080 |
Why?
|
Muscarinic Antagonists | 3 | 2015 | 136 | 0.080 |
Why?
|
Adult | 42 | 2021 | 217986 | 0.080 |
Why?
|
Kidney Calices | 1 | 2009 | 26 | 0.080 |
Why?
|
Testicular Hydrocele | 1 | 2008 | 27 | 0.080 |
Why?
|
Neurologic Examination | 5 | 1997 | 910 | 0.080 |
Why?
|
International Cooperation | 1 | 2015 | 1427 | 0.080 |
Why?
|
Rupture, Spontaneous | 2 | 2004 | 352 | 0.080 |
Why?
|
Rats | 5 | 2021 | 23588 | 0.080 |
Why?
|
Disease Progression | 3 | 2017 | 13427 | 0.080 |
Why?
|
Spermatic Cord Torsion | 2 | 2005 | 73 | 0.080 |
Why?
|
Urachus | 2 | 1998 | 18 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2012 | 15682 | 0.080 |
Why?
|
Combined Modality Therapy | 5 | 2018 | 8555 | 0.080 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2009 | 384 | 0.080 |
Why?
|
Urolithiasis | 1 | 2009 | 132 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3596 | 0.070 |
Why?
|
Nomograms | 1 | 2009 | 239 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3720 | 0.070 |
Why?
|
Kidney Neoplasms | 2 | 2003 | 4307 | 0.070 |
Why?
|
Physical Examination | 3 | 2012 | 1240 | 0.070 |
Why?
|
Sperm Count | 1 | 2007 | 228 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2900 | 0.070 |
Why?
|
Eosinophilia | 1 | 1991 | 556 | 0.070 |
Why?
|
Risk Factors | 9 | 2021 | 73860 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1899 | 0.070 |
Why?
|
Balanitis | 1 | 2005 | 3 | 0.070 |
Why?
|
Choristoma | 2 | 1998 | 210 | 0.070 |
Why?
|
Remission, Spontaneous | 3 | 2009 | 382 | 0.070 |
Why?
|
Endoscopy | 3 | 2017 | 1839 | 0.060 |
Why?
|
Testicular Diseases | 1 | 2005 | 73 | 0.060 |
Why?
|
Benchmarking | 1 | 2012 | 1039 | 0.060 |
Why?
|
Laparoscopy | 3 | 2008 | 2152 | 0.060 |
Why?
|
Scrotum | 3 | 2005 | 116 | 0.060 |
Why?
|
Anxiety | 1 | 2020 | 4484 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14636 | 0.060 |
Why?
|
Ultrasonography | 7 | 2022 | 5937 | 0.060 |
Why?
|
Patient Care Team | 1 | 2016 | 2503 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2015 | 5180 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17703 | 0.060 |
Why?
|
Pyelonephritis | 4 | 1980 | 75 | 0.060 |
Why?
|
Prostheses and Implants | 3 | 1991 | 1272 | 0.060 |
Why?
|
Sympathomimetics | 1 | 2003 | 56 | 0.060 |
Why?
|
Prosthesis Failure | 2 | 2008 | 1216 | 0.060 |
Why?
|
Heterozygote | 2 | 2020 | 2788 | 0.060 |
Why?
|
Microsurgery | 1 | 2008 | 781 | 0.050 |
Why?
|
Observer Variation | 1 | 2009 | 2593 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3686 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2011 | 2270 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 3-gamma | 1 | 2022 | 10 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9561 | 0.050 |
Why?
|
Radiography | 13 | 1997 | 6975 | 0.050 |
Why?
|
Lipoma | 2 | 1997 | 291 | 0.050 |
Why?
|
Teratoma | 1 | 2006 | 403 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 64 | 0.050 |
Why?
|
Spinal Cord Diseases | 2 | 1988 | 289 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2024 | 555 | 0.050 |
Why?
|
Spinal Cord Neoplasms | 2 | 1997 | 265 | 0.050 |
Why?
|
Motor Neurons | 5 | 1995 | 851 | 0.050 |
Why?
|
Prosthesis Design | 2 | 2008 | 2125 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5784 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18027 | 0.050 |
Why?
|
Circumcision, Male | 2 | 2017 | 148 | 0.050 |
Why?
|
Sex Factors | 4 | 2012 | 10493 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2011 | 1983 | 0.050 |
Why?
|
Replantation | 3 | 1980 | 140 | 0.050 |
Why?
|
Reference Standards | 2 | 2015 | 1005 | 0.050 |
Why?
|
Rhabdomyosarcoma | 2 | 1996 | 359 | 0.050 |
Why?
|
Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2003 | 617 | 0.050 |
Why?
|
Radiopharmaceuticals | 3 | 2000 | 2669 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12073 | 0.050 |
Why?
|
Lithotripsy | 1 | 2001 | 147 | 0.050 |
Why?
|
Animals | 10 | 2021 | 167149 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2012 | 6237 | 0.050 |
Why?
|
Incidence | 6 | 2018 | 21239 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7342 | 0.040 |
Why?
|
Home Nursing | 2 | 1998 | 92 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3779 | 0.040 |
Why?
|
Epispadias | 1 | 1999 | 19 | 0.040 |
Why?
|
Digestive System | 1 | 2000 | 244 | 0.040 |
Why?
|
Arabs | 1 | 2021 | 183 | 0.040 |
Why?
|
Umbilical Arteries | 2 | 1978 | 79 | 0.040 |
Why?
|
Reoperation | 6 | 2009 | 4283 | 0.040 |
Why?
|
Electric Stimulation Therapy | 2 | 2013 | 610 | 0.040 |
Why?
|
Larva | 1 | 2020 | 511 | 0.040 |
Why?
|
Phenotype | 4 | 2020 | 16478 | 0.040 |
Why?
|
Signal Transduction | 2 | 2017 | 23278 | 0.040 |
Why?
|
Disorders of Sex Development | 1 | 1999 | 129 | 0.040 |
Why?
|
Xenopus | 1 | 2020 | 712 | 0.040 |
Why?
|
Electrophysiology | 4 | 1997 | 1264 | 0.040 |
Why?
|
Chondrocytes | 1 | 2003 | 791 | 0.040 |
Why?
|
Genetic Counseling | 2 | 1979 | 619 | 0.040 |
Why?
|
Severity of Illness Index | 5 | 2015 | 15746 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1735 | 0.040 |
Why?
|
Urogenital System | 1 | 2018 | 88 | 0.040 |
Why?
|
Gestational Age | 1 | 2006 | 3557 | 0.040 |
Why?
|
DNA | 2 | 2003 | 7225 | 0.040 |
Why?
|
Vaginal Diseases | 1 | 1998 | 104 | 0.040 |
Why?
|
Prospective Studies | 7 | 2020 | 53991 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 36042 | 0.030 |
Why?
|
Exons | 2 | 2018 | 2388 | 0.030 |
Why?
|
Umbilical Cord | 1 | 1978 | 181 | 0.030 |
Why?
|
Nervous System | 1 | 2000 | 540 | 0.030 |
Why?
|
Methods | 5 | 1990 | 1077 | 0.030 |
Why?
|
Genome, Human | 1 | 2009 | 4407 | 0.030 |
Why?
|
Kyphosis | 1 | 1998 | 237 | 0.030 |
Why?
|
Chromosome Mapping | 3 | 2011 | 4629 | 0.030 |
Why?
|
Reflex, Abnormal | 2 | 1994 | 82 | 0.030 |
Why?
|
Prenatal Care | 1 | 2003 | 1115 | 0.030 |
Why?
|
Ileum | 3 | 1989 | 557 | 0.030 |
Why?
|
Vaginal Neoplasms | 1 | 1996 | 106 | 0.030 |
Why?
|
Ureteral Diseases | 2 | 1989 | 65 | 0.030 |
Why?
|
Consanguinity | 1 | 2018 | 454 | 0.030 |
Why?
|
Cystitis | 3 | 1994 | 96 | 0.030 |
Why?
|
Lumbosacral Plexus | 1 | 1995 | 50 | 0.030 |
Why?
|
Risk Assessment | 3 | 2018 | 23956 | 0.030 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2015 | 174 | 0.030 |
Why?
|
Mice | 6 | 2020 | 80745 | 0.030 |
Why?
|
Perineum | 1 | 1996 | 210 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2015 | 296 | 0.030 |
Why?
|
Urinary Fistula | 1 | 1994 | 43 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2002 | 1744 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2018 | 1165 | 0.030 |
Why?
|
Cutaneous Fistula | 1 | 1994 | 80 | 0.030 |
Why?
|
Nephrology | 1 | 2017 | 236 | 0.030 |
Why?
|
Muscular Dystrophies | 1 | 1996 | 388 | 0.030 |
Why?
|
Botulinum Toxins | 1 | 2015 | 189 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2013 | 20404 | 0.030 |
Why?
|
Hypertrophy | 2 | 2007 | 556 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2003 | 2868 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2018 | 827 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2018 | 2755 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3675 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1101 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2292 | 0.030 |
Why?
|
Boston | 4 | 2017 | 9254 | 0.030 |
Why?
|
Urinary Incontinence, Stress | 1 | 2015 | 185 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1785 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2018 | 1064 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14330 | 0.030 |
Why?
|
China | 1 | 2019 | 2337 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2015 | 880 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15589 | 0.030 |
Why?
|
Behavior Therapy | 2 | 2013 | 860 | 0.030 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 12926 | 0.030 |
Why?
|
Nervous System Diseases | 2 | 1996 | 1627 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2667 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 986 | 0.030 |
Why?
|
Laxatives | 1 | 2013 | 88 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3469 | 0.030 |
Why?
|
Prenatal Diagnosis | 2 | 2017 | 1270 | 0.020 |
Why?
|
Rhombencephalon | 1 | 2012 | 82 | 0.020 |
Why?
|
Cicatrix | 2 | 2012 | 778 | 0.020 |
Why?
|
Ostomy | 1 | 2011 | 29 | 0.020 |
Why?
|
Models, Animal | 1 | 2018 | 2117 | 0.020 |
Why?
|
Age Distribution | 1 | 1997 | 2887 | 0.020 |
Why?
|
Clinical Alarms | 1 | 2012 | 61 | 0.020 |
Why?
|
Surgical Stomas | 1 | 2011 | 42 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 1992 | 216 | 0.020 |
Why?
|
Sleep Apnea, Central | 1 | 2012 | 88 | 0.020 |
Why?
|
Logistic Models | 2 | 2015 | 13315 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 4488 | 0.020 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2012 | 186 | 0.020 |
Why?
|
Genital Neoplasms, Male | 1 | 1990 | 68 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2013 | 464 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6890 | 0.020 |
Why?
|
Prolapse | 1 | 1990 | 63 | 0.020 |
Why?
|
Recurrence | 4 | 2011 | 8441 | 0.020 |
Why?
|
Electrolytes | 1 | 2011 | 281 | 0.020 |
Why?
|
Catheterization | 1 | 1975 | 1430 | 0.020 |
Why?
|
Constriction, Pathologic | 2 | 2011 | 1105 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 12491 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 1975 | 588 | 0.020 |
Why?
|
Evaluation Studies as Topic | 3 | 1989 | 1635 | 0.020 |
Why?
|
Mesencephalon | 1 | 2012 | 329 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2250 | 0.020 |
Why?
|
Base Sequence | 2 | 2015 | 12444 | 0.020 |
Why?
|
Family | 1 | 2020 | 3181 | 0.020 |
Why?
|
Contrast Media | 1 | 2022 | 5293 | 0.020 |
Why?
|
Cohort Studies | 4 | 2015 | 41119 | 0.020 |
Why?
|
Dilatation, Pathologic | 4 | 1989 | 518 | 0.020 |
Why?
|
Lod Score | 1 | 2009 | 602 | 0.020 |
Why?
|
Risk | 4 | 1984 | 9624 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2011 | 598 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9310 | 0.020 |
Why?
|
Medical History Taking | 1 | 2012 | 776 | 0.020 |
Why?
|
Netherlands | 1 | 2013 | 2204 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2667 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17611 | 0.020 |
Why?
|
Reflex | 1 | 1989 | 371 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5417 | 0.020 |
Why?
|
Siblings | 1 | 2011 | 826 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2931 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 7828 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 2011 | 495 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2012 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 21907 | 0.020 |
Why?
|
Ischemia | 1 | 1995 | 1892 | 0.020 |
Why?
|
Radionuclide Imaging | 3 | 2000 | 1978 | 0.020 |
Why?
|
Pregnancy | 3 | 2003 | 29543 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 2012 | 748 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12348 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4233 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 13434 | 0.020 |
Why?
|
Surgical Flaps | 1 | 1994 | 1661 | 0.020 |
Why?
|
Psychometrics | 1 | 2015 | 3027 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2011 | 1180 | 0.020 |
Why?
|
Scoliosis | 1 | 2012 | 726 | 0.020 |
Why?
|
Walking | 1 | 1992 | 1176 | 0.020 |
Why?
|
Postoperative Period | 2 | 2006 | 1820 | 0.020 |
Why?
|
Thymine | 1 | 2004 | 69 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4722 | 0.010 |
Why?
|
Infertility, Male | 1 | 2007 | 395 | 0.010 |
Why?
|
Kidney Tubules | 1 | 2006 | 449 | 0.010 |
Why?
|
Congenital Abnormalities | 2 | 1998 | 705 | 0.010 |
Why?
|
Jejunum | 1 | 1985 | 471 | 0.010 |
Why?
|
Kidney Glomerulus | 1 | 2006 | 565 | 0.010 |
Why?
|
Sertoli Cell Tumor | 1 | 1983 | 36 | 0.010 |
Why?
|
Cytosine | 1 | 2004 | 211 | 0.010 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1983 | 67 | 0.010 |
Why?
|
Guanine | 1 | 2004 | 277 | 0.010 |
Why?
|
Pentetic Acid | 1 | 1983 | 209 | 0.010 |
Why?
|
Technetium | 1 | 1983 | 321 | 0.010 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 1983 | 102 | 0.010 |
Why?
|
Proline | 1 | 2004 | 456 | 0.010 |
Why?
|
Genitalia, Female | 1 | 1983 | 147 | 0.010 |
Why?
|
Algorithms | 2 | 2015 | 13952 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2003 | 256 | 0.010 |
Why?
|
Urothelium | 1 | 2004 | 277 | 0.010 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2002 | 169 | 0.010 |
Why?
|
Retreatment | 1 | 2003 | 599 | 0.010 |
Why?
|
Alanine | 1 | 2004 | 593 | 0.010 |
Why?
|
Postoperative Care | 2 | 1999 | 1473 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2846 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11028 | 0.010 |
Why?
|
Introns | 1 | 2004 | 974 | 0.010 |
Why?
|
Linear Models | 2 | 2005 | 5863 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1999 | 11898 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1986 | 1200 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2003 | 692 | 0.010 |
Why?
|
Cardiomegaly | 1 | 2003 | 593 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5566 | 0 |